感染性肠炎后肠易激综合征的患病率、危险因素与结局:系统综述与Meta分析
该系统综述与Meta分析纳入45项队列研究、共21421例肠炎患者,随访3个月至10年。感染性肠炎后12个月肠易激综合征(IBS)汇总患病率为10.1%(95%CI 7.2-14.1),超过12个月为14.5%(95%CI 7.7-25.5);既往12个月内感染性肠炎者IBS风险为无感染者4.2倍(95%CI 3.1-5.7),超过12个月者为2.3倍(95%CI 1.8-3.0)。
要点
- 感染性肠炎后12个月IBS汇总患病率10.1%,超过12个月为14.5%。
- 既往12个月内感染性肠炎者IBS风险为无感染者4.2倍(95%CI 3.1-5.7)。
- 女性、抗生素暴露及焦虑、抑郁、躯体化、神经质增加感染后IBS风险。
核心结论
- 系统综述与Meta分析发现超过10%的感染性肠炎患者日后发生IBS。
- 感染性肠炎者IBS风险约为无感染者的4倍,但分析的研究间存在异质性。
- 女性尤其重型肠炎者、心理困扰者及肠炎期间使用抗生素者发生IBS风险增加。
研究设计与样本
- 系统检索1994年至2015年8月31日的电子数据库,纳入感染性肠炎后3个月及以上IBS患病率的队列研究。
- 共纳入45项研究、21421例肠炎患者,随访3个月至10年以观察IBS发生。
- 采用随机效应Meta分析计算IBS汇总点患病率、相对风险及宿主与肠炎相关危险因素。
主要发现
- 感染性肠炎后12个月IBS汇总患病率为10.1%(95%CI 7.2-14.1),超过12个月为14.5%(95%CI 7.7-25.5)。
- 既往12个月内感染性肠炎者IBS风险为无感染者4.2倍(95%CI 3.1-5.7),超过12个月者为2.3倍(95%CI 1.8-3.0)。
- 原虫或寄生虫所致肠炎者41.9%发生IBS,细菌感染所致肠炎者13.8%发生IBS。
- 女性IBS风险升高(OR 2.2;95%CI 1.6-3.1),抗生素暴露者OR 1.7(95%CI 1.2-2.4),焦虑者OR 2(95%CI 1.3-2.9),抑郁者OR 1.5(95%CI 1.2-1.9),躯体化者OR 4.1(95%CI 2.7-6.0),神经质者OR 3.3(95%CI 1.6-6.5)。
- 肠炎严重程度的临床指标亦与IBS风险升高相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究间存在相当程度的异质性。
- 分析的研究间存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Foodborne illness affects 15% of the US population each year, and is a risk factor for irritable bowel syndrome (IBS). We evaluated risk of, risk factors for, and outcomes of IBS after infectious enteritis. METHODS: We performed a systematic review of electronic databases from 1994 through August 31, 2015 to identify cohort studies of the prevalence of IBS 3 months or more after infectious enteritis. We used random-effects meta-analysis to calculate the summary point prevalence of IBS after infectious enteritis, as well as relative risk (compared with individuals without infectious enteritis) and host- and enteritis-related risk factors. RESULTS: We identified 45 studies, comprising 21,421 individuals with enteritis, followed for 3 months to 10 years for development of IBS. The pooled prevalence of IBS at 12 months after infectious enteritis was 10.1% (95% confidence interval [CI], 7.2-14.1) and at more than 12 months after infectious enteritis was 14.5% (95% CI, 7.7-25.5). Risk of IBS was 4.2-fold higher in patients who had infectious enteritis in the past 12 months than in those who had not (95% CI, 3.1-5.7); risk of IBS was 2.3-fold higher in individuals who had infectious enteritis more than 12 months ago than in individuals who had not (95% CI, 1.8-3.0). Of patients with enteritis caused by protozoa or parasites, 41.9% developed IBS, and of patients with enteritis caused by bacterial infection, 13.8% developed IBS. Risk of IBS was significantly increased in women (odds ratio [OR], 2.2; 95% CI, 1.6-3.1) and individuals with antibiotic exposure (OR, 1.7; 95% CI, 1.2-2.4), anxiety (OR, 2; 95% CI, 1.3-2.9), depression (OR, 1.5; 95% CI, 1.2-1.9), somatization (OR, 4.1; 95% CI, 2.7-6.0), neuroticism (OR, 3.3; 95% CI, 1.6-6.5), and clinical indicators of enteritis severity. There was a considerable level of heterogeneity among studies. CONCLUSIONS: In a systematic review and meta-analysis, we found >10% of patients with infectious enteritis develop IBS later; risk of IBS was 4-fold higher than in individuals who did not have infectious enteritis, although there was heterogeneity among studies analyzed. Women-particularly those with severe enteritis-are at increased risk for developing IBS, as are individuals with psychological distress and users of antibiotics during the enteritis.
引用
- Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017. PMID: 28069350. doi:10.1053/j.gastro.2016.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。